These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2206824)

  • 1. Breakthrough seizures with generic carbamazepine: a consequence of poorer bioavailability?
    Hartley R; Aleksandrowicz J; Ng PC; McLain B; Bowmer CJ; Forsythe WI
    Br J Clin Pract; 1990 Jul; 44(7):270-3. PubMed ID: 2206824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution and relative bioavailability of two carbamazepine preparations for children with epilepsy.
    Hartley R; Aleksandrowicz J; Bowmer CJ; Cawood A; Forsythe WI
    J Pharm Pharmacol; 1991 Feb; 43(2):117-9. PubMed ID: 1672895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter, placebo-controlled, double-blind study of efficacy of a new form of carbamazepine (Carbatrol) in refractory epileptic patients.
    Sobaniec W; Kułak W; Smigielska-Kuzia J; Boćkowski L; Majkowski J; Jedrzejczak J
    Pol J Pharmacol; 2004; 56(2):195-201. PubMed ID: 15156070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cognitive and psychomotor effects of remacemide and carbamazepine in newly diagnosed epilepsy.
    Wesnes KA; Edgar C; Dean AD; Wroe SJ
    Epilepsy Behav; 2009 Mar; 14(3):522-8. PubMed ID: 19111629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steady state concentrations and diurnal fluctuations of carbamazepine in patients after different slow release formulations.
    Wolf P; May T; Tiska G; Schreiber G
    Arzneimittelforschung; 1992 Mar; 42(3):284-8. PubMed ID: 1497685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of bioavailability and clinical efficacy of carbamazepine in epileptic patients.
    Silpakit O; Amornpichetkoon M; Kaojarern S
    Ann Pharmacother; 1997 May; 31(5):548-52. PubMed ID: 9161646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Monotherapy with carbamazepine in childhood epilepsies].
    Dulac O; Bouguerra L; Rey E; de Lauture D; Arthuis M
    Arch Fr Pediatr; 1983 May; 40(5):415-9. PubMed ID: 6411042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine and its epoxide: an open study of efficacy and side effects after carbamazepine dose increment in refractory partial epilepsy.
    Semah F; Gimenez F; Longer E; Laplane D; Thuillier A; Baulac M
    Ther Drug Monit; 1994 Dec; 16(6):537-40. PubMed ID: 7878690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once daily dosage versus divided daily doses of carbamazepine therapy in epileptic patients: a pilot study.
    Ghose K; Dawson M; Fry DE; Christofides JA
    Pharmatherapeutica; 1981; 3(1):71-8. PubMed ID: 7033994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbamazepine monotherapy in epileptic out-patients.
    Andersen EB; Philbert A; Klee JG
    Acta Neurol Scand Suppl; 1983; 94():29-34. PubMed ID: 6410672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of add-on melatonin administration on antioxidant enzymes in children with epilepsy taking carbamazepine monotherapy: a randomized, double-blind, placebo-controlled trial.
    Gupta M; Gupta YK; Agarwal S; Aneja S; Kalaivani M; Kohli K
    Epilepsia; 2004 Dec; 45(12):1636-9. PubMed ID: 15571523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on carbamazepine serum level in epileptic patients treated only with carbamazepine: with special reference to its efficacy and side effects (author's transl)].
    Kaneko S; Suzuki K; Fukushima Y; Sato T
    Seishin Shinkeigaku Zasshi; 1978 Sep; 80(9):537-60. PubMed ID: 724824
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combination therapy with carbamazepine and valproic acid in problem cases at an outpatient epilepsy clinic].
    Fröscher W; Stoll KD; Hoffmann F
    Arzneimittelforschung; 1984; 34(8):910-4. PubMed ID: 6437416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum lipid levels during carbamazepine therapy in epileptic children.
    Mahmoudian T; Iranpour R; Messri N
    Epilepsy Behav; 2005 Mar; 6(2):257-9. PubMed ID: 15710313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
    Miller AD; Krauss GL; Hamzeh FM
    Acta Neurol Scand; 2004 Jun; 109(6):374-7. PubMed ID: 15147458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to carbamazepine in children with newly diagnosed partial onset epilepsy.
    Holland KD; Glauser TA
    Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakthrough seizures with generic carbamazepine?
    Hartley R; Aleksandrowicz J; Ng PC; McLain B; Bowmer CJ; Forsythe WI
    Dev Med Child Neurol; 1990 May; 32(5):460-2. PubMed ID: 2113017
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative bioavailability of carbamazepine from two slow-release preparations.
    Reunanen M; Heinonen EH; Nyman L; Anttila M
    Epilepsy Res; 1992 Mar; 11(1):61-6. PubMed ID: 1563339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of steady-state blood levels of two carbamazepine formulations.
    Jumao-as A; Bella I; Craig B; Lowe J; Dasheiff RM
    Epilepsia; 1989; 30(1):67-70. PubMed ID: 2912719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the biological availability of 2 carbamazepine preparations].
    Niedzielska K; Rosnowska M; Kuran W
    Neurol Neurochir Pol; 1986; 20(5):415-20. PubMed ID: 3295573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.